ArticleThe international journal of biochemistry & cell biology2026
Modulatory effects of exogenous estradiol during endotoxemia.
Article in The international journal of biochemistry & cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
This study explores the effects of exogenous estradiol on inflammatory, metabolic, and organ-function responses to lipopolysaccharide (LPS)-induced endotoxemia using a murine model. Male, female, and estradiol-supplemented female mice were administered equal dose of LPS injections and observed over a 6-hour period for systemic physiological changes, including blood pressure, glomerular filtration rate (GFR), blood gases, and temperature. Post-mortem analyses evaluated inflammatory pathway markers, biomarkers of organ injury, and targeted metabolomics from plasma samples. Estradiol supplementation was associated with attenuated early markers of hepatic and cardiac injury, reduced cardiac nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) expression, and changes from baseline post-LPS on metabolite profiles compared with control female and male mice. These effects were organ- and endpoint-dependent, with renal functional differences emerging primarily at later time points. Metabolite changes involving L-carnitine, methionine sulfoxide, and octanoic acid were consistent with altered metabolic and redox responses, but do not directly demonstrate changes in mitochondrial or antioxidant function. Together, these findings indicate that elevated estradiol levels are associated with modulation of early inflammatory and metabolic responses during endotoxemia, rather than uniform protection across organs or sexes. This work highlights biological sex and hormonal status as important variables in endotoxemia models and provides hypothesis-generating evidence for future studies examining hormone-dependent regulation of immune-metabolic pathways during systemic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.